Form D · Pharmaceuticals
CutisPharma, Inc.
Wilmington, MA · CIK 0001628863
Offering snapshot reported Dec 30, 2014 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2014 | Initial | $20,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $639K
- Finders' fees
- $0
- Form D file number
- 021-231093
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Johnston Blakely & Company, LLC | 140203 | Benjamin J. Conway · CRD 1712119 |
Source: Form D, filed Dec 30, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric B Lev | Director |
| Peter Mione | Director, Executive |
| Indu Muni | Director, Executive |
| Neal Muni | Director, Executive |
| David J. Parker | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
841 Woburn Street
Wilmington, MA, 01887
Wilmington, MA, 01887